Alkem’s API Facility in Ankleshwar gets USFDA inspection report

12 Dec 2016 Evaluate

Alkem’s API Facility in Ankleshwar was inspected by the US Food and Drug Administration (USFDA) from December 5, 2016 to December 9, 2016. The Company has received the inspection report which contains three 483 observations. The Company shall put together a detailed response with adequate corrective and preventive measures to address the USFDA Observations and the same is proposed to be filed within the timeline stipulated by USFDA.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5442.45 10.60 (0.20%)
23-Dec-2024 10:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.30
Dr. Reddys Lab 1347.50
Cipla 1479.00
Lupin 2177.70
Zydus Lifesciences 975.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.